• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脊髓灰质炎病毒中和表位:用中和性单克隆抗体进行分析和定位

Poliovirus neutralization epitopes: analysis and localization with neutralizing monoclonal antibodies.

作者信息

Emini E A, Jameson B A, Lewis A J, Larsen G R, Wimmer E

出版信息

J Virol. 1982 Sep;43(3):997-1005. doi: 10.1128/JVI.43.3.997-1005.1982.

DOI:10.1128/JVI.43.3.997-1005.1982
PMID:6183443
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC256210/
Abstract

Two hybridomas (H3 and D3) secreting monoclonal neutralizing antibody to intact poliovirus type 1 (Mahoney strain) were established. Each antibody bound to a site qualitatively different from that to which the other antibody bound. The H3 site was located on intact virions and, to a lesser extent, on 80S naturally occurring empty capsids and 14S precursor subunits. The D3 site was found only on virions and empty capsids. Neither site was expressed on 80S heat-treated virions. The antibodies did not react with free denatured or undenatured viral structural proteins. Viral variants which were no longer capable of being neutralized by either one or the other antibody were obtained. Such variants arose during normal cell culture passage of wild-type virus and were present in the progeny viral population on the order of 10(-4) variant per wild-type virus PFU. Toluene-2,4-diisocyanate, a heterobifunctional covalent cross-linking reagent, was used to irreversibly bind the F(ab) fragments of the two antibodies to their respective binding sites. In this way, VP1 was identified as the structural protein containing both sites.

摘要

建立了两种分泌针对完整1型脊髓灰质炎病毒(马奥尼株)的单克隆中和抗体的杂交瘤(H3和D3)。每种抗体结合的位点在性质上与另一种抗体结合的位点不同。H3位点位于完整病毒粒子上,在较小程度上也位于80S天然存在的空衣壳和14S前体亚基上。D3位点仅在病毒粒子和空衣壳上发现。两个位点在80S热处理病毒粒子上均未表达。这些抗体不与游离的变性或未变性病毒结构蛋白反应。获得了不再能被其中任何一种抗体中和的病毒变体。这种变体在野生型病毒的正常细胞培养传代过程中出现,并且在子代病毒群体中的存在比例约为每野生型病毒PFU有10(-4)个变体。使用甲苯-2,4-二异氰酸酯,一种异双功能共价交联试剂,将两种抗体的F(ab)片段不可逆地结合到它们各自的结合位点。通过这种方式确定VP1为包含这两个位点的结构蛋白。

相似文献

1
Poliovirus neutralization epitopes: analysis and localization with neutralizing monoclonal antibodies.脊髓灰质炎病毒中和表位:用中和性单克隆抗体进行分析和定位
J Virol. 1982 Sep;43(3):997-1005. doi: 10.1128/JVI.43.3.997-1005.1982.
2
Binding of neutralizing monoclonal antibodies to empty capsids of poliovirus can be blocked by monospecific antisera to structural polypeptides VP1 and VP2.针对脊髓灰质炎病毒空衣壳的中和性单克隆抗体的结合可被针对结构多肽VP1和VP2的单特异性抗血清阻断。
Arch Virol. 1985;83(3-4):295-303. doi: 10.1007/BF01309924.
3
Mutations conferring resistance to neutralization with monoclonal antibodies in type 1 poliovirus can be located outside or inside the antibody-binding site.1型脊髓灰质炎病毒中赋予对单克隆抗体中和作用抗性的突变可位于抗体结合位点之外或之内。
J Virol. 1986 Jan;57(1):81-90. doi: 10.1128/JVI.57.1.81-90.1986.
4
The use of a monoclonal antibody and of DNA recombinant technology for the localization of a poliovirus neutralization epitope in viral capsid polypeptide VP1.利用单克隆抗体和DNA重组技术对脊髓灰质炎病毒衣壳多肽VP1中一个脊髓灰质炎病毒中和表位进行定位。
Dev Biol Stand. 1984;57:177-85.
5
Application of monoclonal antibodies for the identification of the antigenic site for poliovirus neutralization.单克隆抗体在脊髓灰质炎病毒中和抗原位点鉴定中的应用。
Dev Biol Stand. 1984;57:171-5.
6
Detection by monoclonal antibodies of an antigenic determinant critical for poliovirus neutralization present on VP1 and on heat-inactivated virions.通过单克隆抗体检测脊髓灰质炎病毒中和所必需的、存在于VP1和热灭活病毒体上的抗原决定簇。
Virology. 1983 Apr 30;126(2):707-10. doi: 10.1016/s0042-6822(83)80027-0.
7
Principal and subsidiary antigenic sites of VP1 involved in the neutralization of poliovirus type 3.参与3型脊髓灰质炎病毒中和作用的VP1主要和次要抗原位点。
J Gen Virol. 1985 May;66 ( Pt 5):1159-65. doi: 10.1099/0022-1317-66-5-1159.
8
Monoclonal antibodies reactive with different sites of N and H antigenic particles of poliovirus.与脊髓灰质炎病毒N和H抗原颗粒不同位点反应的单克隆抗体。
J Gen Virol. 1983 Dec;64 ( Pt 12):2803-8. doi: 10.1099/0022-1317-64-12-2803.
9
Monoclonal antibodies reveal in blocking reactions the antigenicity and antibody response of poliovirus.单克隆抗体在阻断反应中揭示了脊髓灰质炎病毒的抗原性和抗体反应。
Dev Biol Stand. 1984;57:187-91.
10
Poliovirus Sabin type 1 neutralization epitopes recognized by immunoglobulin A monoclonal antibodies.脊髓灰质炎病毒1型萨宾株被免疫球蛋白A单克隆抗体识别的中和表位
J Virol. 1997 Sep;71(9):6905-12. doi: 10.1128/JVI.71.9.6905-6912.1997.

引用本文的文献

1
Characterization of Poliovirus Neutralization Escape Mutants of Single-Domain Antibody Fragments (VHHs).单域抗体片段(VHHs)的脊髓灰质炎病毒中和逃逸突变体的表征
Antimicrob Agents Chemother. 2015 Aug;59(8):4695-706. doi: 10.1128/AAC.00878-15. Epub 2015 May 26.
2
The compatibility of inactivated-Enterovirus 71 vaccination with Coxsackievirus A16 and Poliovirus immunizations in humans and animals.人用和兽用肠道病毒71型灭活疫苗与柯萨奇病毒A16型和脊髓灰质炎病毒疫苗的兼容性。
Hum Vaccin Immunother. 2015;11(11):2723-33. doi: 10.1080/21645515.2015.1011975. Epub 2015 Feb 25.
3
Cross-neutralizing human anti-poliovirus antibodies bind the recognition site for cellular receptor.交叉中和人抗脊髓灰质炎病毒抗体结合细胞受体的识别位点。
Proc Natl Acad Sci U S A. 2013 Dec 10;110(50):20242-7. doi: 10.1073/pnas.1320041110. Epub 2013 Nov 25.
4
Detection of unusual mutation within the VP1 region of different re-isolates of poliovirus Sabin vaccine.脊髓灰质炎病毒Sabin疫苗不同再分离株VP1区域异常突变的检测
Virus Genes. 2006 Oct;33(2):183-91. doi: 10.1007/s11262-005-0055-3.
5
Probiotic bacteria stimulate virus-specific neutralizing antibodies following a booster polio vaccination.在脊髓灰质炎疫苗加强接种后,益生菌可刺激产生病毒特异性中和抗体。
Eur J Nutr. 2005 Oct;44(7):406-13. doi: 10.1007/s00394-004-0541-8. Epub 2004 Dec 1.
6
Antibody responses to antigenic sites 1 and 3 of serotype 3 poliovirus after vaccination with oral live attenuated or inactivated poliovirus vaccine and after natural exposure.口服减毒活脊髓灰质炎病毒疫苗或灭活脊髓灰质炎病毒疫苗接种后以及自然暴露后,针对3型脊髓灰质炎病毒抗原位点1和3的抗体反应。
Clin Diagn Lab Immunol. 2000 Jan;7(1):40-4. doi: 10.1128/CDLI.7.1.40-44.2000.
7
Evaluation of a poliovirus-binding inhibition assay as an alternative to the virus neutralization test.评估脊髓灰质炎病毒结合抑制试验作为病毒中和试验的替代方法。
Clin Diagn Lab Immunol. 1997 Nov;4(6):659-64. doi: 10.1128/cdli.4.6.659-664.1997.
8
Attenuated Mengo virus as a vector for immunogenic human immunodeficiency virus type 1 glycoprotein 120.减毒门戈病毒作为免疫原性人免疫缺陷病毒1型糖蛋白120的载体。
Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):9775-9. doi: 10.1073/pnas.91.21.9775.
9
Monoclonal antibodies to Rhizobium meliloti and surface mutants insensitive to them.针对苜蓿根瘤菌的单克隆抗体及其对这些抗体不敏感的表面突变体。
J Bacteriol. 1984 Oct;160(1):454-7. doi: 10.1128/jb.160.1.454-457.1984.
10
The application of monoclonal antibodies in the study of viruses.单克隆抗体在病毒研究中的应用。
Adv Virus Res. 1984;29:95-130. doi: 10.1016/s0065-3527(08)60406-6.

本文引用的文献

1
The hydrolysis of rabbit y-globulin and antibodies with crystalline papain.用结晶木瓜蛋白酶对兔γ球蛋白和抗体进行水解。
Biochem J. 1959 Sep;73(1):119-26. doi: 10.1042/bj0730119.
2
The D to C change in poliovirus particles.脊髓灰质炎病毒颗粒从D型到C型的变化。
Br J Exp Pathol. 1959 Dec;40(6):605-20.
3
Principles of immunization as applied to poliomyelitis and influenza.应用于脊髓灰质炎和流感的免疫原则。
Am J Public Health Nations Health. 1953 Nov;43(11):1384-98. doi: 10.2105/ajph.43.11.1384.
4
Picornaviral structure and assembly.小核糖核酸病毒的结构与组装
Microbiol Rev. 1981 Jun;45(2):287-315. doi: 10.1128/mr.45.2.287-315.1981.
5
Identification of the initiation site of poliovirus polyprotein synthesis.脊髓灰质炎病毒多聚蛋白合成起始位点的鉴定
J Virol. 1982 Jun;42(3):1017-28. doi: 10.1128/JVI.42.3.1017-1028.1982.
6
Carboxy-terminal analysis of poliovirus proteins: termination of poliovirus RNA translation and location of unique poliovirus polyprotein cleavage sites.脊髓灰质炎病毒蛋白的羧基末端分析:脊髓灰质炎病毒RNA翻译的终止及脊髓灰质炎病毒独特多蛋白裂解位点的定位
J Virol. 1982 Apr;42(1):194-9. doi: 10.1128/JVI.42.1.194-199.1982.
7
Cleavage sites within the poliovirus capsid protein precursors.脊髓灰质炎病毒衣壳蛋白前体中的切割位点。
J Virol. 1982 Jan;41(1):340-4. doi: 10.1128/JVI.41.1.340-344.1982.
8
Multiple genetic changes can occur in the oral poliovaccines upon replication in humans.
J Gen Virol. 1981 Oct;56(Pt 2):337-47. doi: 10.1099/0022-1317-56-2-337.
9
The fate of VPg during in vitro translation of poliovirus RNA.脊髓灰质炎病毒RNA体外翻译过程中VPg的命运。
FEBS Lett. 1981 Sep 28;132(2):219-23. doi: 10.1016/0014-5793(81)81164-7.
10
A neutralizing monoclonal antibody against poliovirus and its reaction with related antigens.一种抗脊髓灰质炎病毒的中和单克隆抗体及其与相关抗原的反应。
Virology. 1981 Nov;115(1):211-5. doi: 10.1016/0042-6822(81)90103-3.